Adam Pascale, CFO at HEMISPHERX BIOPHARMA INC (HEB), bought 6,981 shares at $0.46 ($3K) on 2017-02-16, disclosed to the SEC on 2017-02-21.
Open-market purchase of $3k HEB by CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Several strong factors at once. The rarest rating we give.
| Filing → |